Last updated on December 2019

Trial to Evaluate the Safety ofTalimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab


Find a site near you

Start Over

Research Site

Los Angeles, CA United States
  Connect »

Research Site

Washington, WA United States
  Connect »

Research Site

Louisville, KY United States
  Connect »

Research Site

Saint Louis, MO United States
  Connect »

Research Site

New Brunswick, NJ United States
  Connect »

Research Site

New York, NY United States
  Connect »

Research Site

Houston, TX United States
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Seongnam-si, Gyeonggi-do, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Barcelona, Spain
  Connect »

Research Site

Geneva 14, Switzerland
  Connect »

Research Site

Lausanne, Switzerland
  Connect »

Research Site

Winterthur, Switzerland
  Connect »

Research Site

Zurich, Switzerland
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Pittsburgh, PA United States
  Connect »

Research Site

Salzburg, Austria
  Connect »

Research Site

Tübingen, Germany
  Connect »